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Abstract
Objective: Alexithymia has been considered both to predispose to depression and to worsen cardiac prognosis after an acute coronary
syndrome. Nonetheless, no studies have evaluated its role as a risk factor for incident depression, in patients with acute coronary syndrome.
Methods: In 251 consecutive patients, the presence of a first-ever depressive episode was evaluated with the Primary Care Evaluation of
Mental Disorders at baseline and 1, 2, 4, 6, 9, 12 and 24 months after their first acute coronary syndrome. At baseline, patients completed the
Toronto Alexithymia Scale (TAS-20) and the Hospital Anxiety and Depression Scale.
Results: Out of 251 subjects (80.9% males), a first-ever depressive episode was diagnosed in 66 patients. Depressed and never-depressed
patients differed in female gender, living status, alexithymic scores at TAS-20 and depressive symptoms. Nonetheless, nor the TAS-20
factors nor its total score were predictive of developing a depressive episode in a Cox regression. Moreover, baseline differences in TAS-20
scores between the two groups, disappeared after controlling for anhedonic symptoms.
Conclusion: Our results do not support the hypothesis that alexithymia at TAS-20 is a risk factor for incident depression after acute
coronary syndrome.
© 2015 Elsevier Inc. All rights reserved.
1. Introduction
Alexithymia is a multidimensional construct characterized
by an impoverished fantasy life, difficulty in expressing or
naming feelings, difficulty distinguishing between bodily
sensations and feelings and a preoccupation with external
events [1]. The TAS-20 [2,3] is the most widely used and
studied self-report measure of alexithymia. Factor analysis has
supported a three-factor solution for this scale: (1) difficulty
identifying feelings (DIF), (2) difficulty communicating and
describing feelings (DDF), and (3) external-oriented thinking
(EOT). Items representing impoverished fantasy or reduced
daydreaming were dropped from the TAS-20 based on the
factor analysis.
Alexithymia, reflecting a disordered affect regulation, is
thought to increase vulnerability to several medical disor-
ders, such as rheumatoid arthritis, essential hypertension,
cardiac disease, stroke, peptic ulcer, inflammatory bowel
disease, breast cancer, diabetes and kidney failure [4].
Moreover, high levels of alexithymia [5,6] or high rates of
alexithymic subjects (21–32%) [7–9] were found in patients
with coronary artery disease, suggesting that alexithymia
could be a risk factor for it [10–12].
Alexithymia is also supposed to be a risk factor for the
development of mental disorders, such as major depression
[1,13,14], panic disorder, eating disorders and substance use
disorders [15,16].
The association between depression and acute coronary
syndrome is well-established [17] and depression is
observed in 19.8% of patients who survive acute myocardial
infarction [18].
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Depression in patients with acute coronary syndrome is
associated with a worse cardiac outcome [19] due to an
increase recurrence of cardiac events and mortality [20].
Moreover, a specific type of depression [21], characterized
by higher anhedonia levels, has been supposed to be
specifically related to cardiac outcome [22,23]. Risk factors
for the development of depression after acute coronary
syndrome have been also identified: younger age [24];
female gender [25] low level of education [26]; low
socio-economic status [27]; having no close friend [28];
being unemployed and living alone [29]; type D personality
[30]; psychological vulnerabilities (i.e. exhaustion, fatigue,
interpersonal difficulties, cognitive distortions) [31–33]; the
presence of depressive symptoms in the few days after an
acute coronary syndrome [34,35]; and the severity of the
acute coronary syndrome [24,36,37].
To our knowledge, no study investigated in patients with
acute coronary syndrome whether alexithymia predicted the
development of major depression. Previous studies observed
that alexithymia was significantly related with anxiety and
depression in acute coronary syndrome patients [9,11,38] and
one study suggested that alexithymia is a consequence of acute
myocardial infarction [38]. Furthermore, all the studies
investigating alexithymia in coronary artery disease enrolled
patientswith previous episodes of coronary disease andmost of
these studies found an association between TAS-20 scores and
pervious myocardial infarction or angina episodes [6–8,38].
These findings questioned whether the TAS-20 could
measure negative affects associated with a general distress
syndrome [15] or with a depressive episode [39] induced by
recurrent episodes of coronary disease rather than alexithy-
mia itself.
Therefore, the aim of this study is to evaluate whether
alexithymia predicted the development of depressive
episodes in never depressed patients at their first acute
coronary syndrome.
2. Materials and methods
2.1. Sample
The study sample was selected among patients who were
consecutively admitted to an Italian Coronary Intensive Care
Unit from January 2009 to March 2012, for an acute
coronary syndrome.
The local ethic committee has approved the study
protocol, all the participants gave their informed consent
after the study was fully explained and the study has been
conducted according the Helsinki Declaration.
Patients were included in the study if at the time of
enrolment: (1) their agewas over 18 years; (2) theywere native
Italian speaker or with a proficiency in Italian; (3) they had no
previous or current major depressive episode according
DSM-IV [40]; (4) they had no substance abuse or dependence;
(5) they did not show cognitive impairment as demonstrated by
aMiniMental State Examination (MMSE) [41] lower than 25;
and (6) they did not take any psychotropicmedication. (7) They
presented for the first time with symptoms suggestive of an
acute coronary syndrome and in whom an ST-segment
elevation myocardial infarction (STEMI), a non–ST-segment
elevation myocardial infarction (NSTEMI), or unstable angina
had been diagnosed [24,43]. The working diagnosis of
NSTE-acute coronary syndrome was a rule-out diagnosis
based on the ECG, i.e. lack of persistent ST elevation.
Biomarkers (troponins) further distinguished NSTEMI and
unstable angina [42].
2.2. Assessment
All patients underwent the following evaluations at
baseline: (1) a brief socio-demographic interview; (2) the
Primary Care Evaluation of Mental Disorder (PRIME-MD)
[44] to diagnose current or previous depressive episodes; (3)
the Hospital Anxiety and Depression Scale (HADS) [45] that
generates two subscale scores: the anxiety score (HADS-A)
and the depression score (HADS-D); and (4) the Toronto
Alexithymia Scale, 20 items (TAS-20) [2,3]. The TAS-20
generated four scores: difficulty identifying feelings (DIF)
score, difficulty describing, communicating and expressing
feelings to others (DDF) score, externally oriented thinking
(EOT) score and TAS-20 total scores. A total score higher
than 60 has been proposed to define someone as alexithymic.
In this sample, the internal consistency for the TAS total
score was α = .77; (5) they were assigned a GRACE score
which assesses mortality risk after acute coronary events
[46]. The Global Registry of Acute Coronary Events
(GRACE) score [47] is based on a risk model of 6 months
mortality risk from the time of hospital discharge; it
considers age, history of MI, past or current congestive
heart failure (CHF), heart rate, systolic blood pressure, serum
creatinine, elevated cardiac enzymes, ST-segment depres-
sion on ECG at admission, and no in hospital percutaneous
intervention (PCI). All the information concerning the
abovementioned parameters was obtained from chart review
at baseline. The GRACE score ranges between 1 and 263
points. A score of 80 predicts a 1% mortality rate at six
months, 100 predicts a 2% mortality rate, and N210 predicts
a N50% mortality rate.
After the inclusion in the study, patients were re-evaluated
one, two, four, six, nine, twelve and twenty-four months later
with the PRIME-MD followed by a psychiatric interview to
confirm a diagnosis a depressive episode.
2.3. Treatment
Concerning treatment of depression, patients with
depressive symptoms were referred to a psychiatrist, and
properly treated.
2.4. Statistical analyses
After computing the rates of patients classified as
depressed and never-depressed over the course of follow-up,
the baseline differences among groups were evaluated using
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Fisher’s exact test for categorical variables (i.e., gender,
educational, family and occupational status) and t-test with
for continuous variables (i.e. age, GRACE score, HADS and
TAS-20 scores).
Analysis of covariance (ANCOVA) was used to evaluate
whether, at baseline, the difference in TAS-20 scores
among groups remained after controlling for the effect of
depressive symptoms.
Previous results in literature [48,49] confirm the high
correlation found between HADS-A and HADS-D (r = .777,
p b 0.001). In order to avoid collinearity between the
covariates at the ANCOVA, we performed an exploratory
factor analysis of HADS. It identified two main factors: a
first factor named negative affectivity (HADS-NA) where
loaded mainly the items exploring low mood and worries
(items 1, 3, 5, 6, 8, 10, 11 and 13) and a second factor named
loss of pleasure or interest (HADS-LP) (items 2, 4, 7, 9, 12
and 14). Doing so, no more collinearity emerged between the
two predictors (i.e. Tolerance N .02; VIF b 10; r = .158;
p = 0.01; lower % of variance explained by the same small
eigenvalue). Considering previous results [22,23,50] that
suggested that low positive affectivity (i.e. anhedonic
symptoms) is a core feature of depression in cardiac
populations, we used the score of HADS-LP as a covariate
in ANCOVA.
The cumulative incidence of depressive episode has been
calculated over the follow-up as one minus the Kaplan–
Meier survival probability.
A proportional hazard model (Cox regression, enter
method) was used to evaluate which socio-demographic and
clinical variables at baseline predicted the development of a
depressive disorder during the follow-up period. We
collapsed the family status in living alone that remained
significant between the two groups, whereas dividing the
sample in employed and unemployed/retired the differences
were not significant anymore. Therefore, we entered the
presence of a depressive episode as the state variables and its
onset as time variable, whereas gender, living alone and the
TAS-20 have been entered as independent variables.
Since alexithymia is not a unitary construct we performed
separate regressions for each sub-score (i.e. DDF, DIF and
EOT) and for the total score.
We carried out all the analysis using SPSS software
(version 21.0, IBM SPSS Statistics).
3. Results
3.1. Patient characteristics
Three-hundred-and-ninety-seven patients met the inclu-
sion criteria, and among them, 377 agreed to participate in
the study. During the follow-up period 111 patients dropped
(25 moved outside the study area and 21 continued the
rehabilitation treatment in a different hospital after the
enrolment, 65 refused further psychiatric evaluations, 15
passed away). Therefore, the study sample included 251
subjects (female n = 48, 19.1%), with a mean age of 61.3 ±
10.9 years (range 32–87 years).
3.2. Depressive disorder
Throughout the follow-up period, a depressive disorder
was diagnosed in 66 patients (26.3%), of which 26 with
major depression and 40 with minor depression, whereas 185
(73.7%) did not show any depressive disorder during the
2-years of follow-up. Onset of the depressive episode during
the follow-up evaluation is shown in Fig. 1.
3.3. Socio-demographic characteristics
Female gender, being housewife and widowed were more
frequent in the depressed group (Table 1).
3.4. Alexithymia
At baseline, the TAS-20 scores, except for DDF and EOT,
were higher in depressed than in non-depressed patients with
a small medium effect size (DIF: d = 0.47; TAS total score:
d = 0.33). Moreover, based on the odd ratio of the chi-square
test, the odds of patients with a new depressive episode were
3 times higher if they were alexithymic than if they were not
(χ2(1) = 8.7; p = 0.006; OR = 2.97).
Nonetheless, among groups, the differences in TAS-20
scores disappeared after controlling for the effect HADS-LP
scores (ANCOVA, DIF: F = 4.25; df = 1248; p = 0.5;
partial η2 = .008; TAS-20 total score: F = 2.00; df =
1248; p = 0.16; partial η2 = .016).
3.5. Predictors of development of a depressive disorder
At the Cox regression any of the TAS-20 factors was a
significant predictor of the onset of depression (Block 1:
Female Gender OR = 1.21; 95%CI = 0.72–2.05; χ2 =
0.52; p = 0.47; Block 2: Female Gender OR = 1.22;
95%CI = 0.72–2.07; χ2 = 0.53; p = 0.47; Living Alone
OR = 0.97; 95%CI = 0.56–1.68; χ2 = 0.01; p = 0.93;
Block 3: TAS scores, in the four Cox regressions
respectively, DIF OR = 1.01; 95%CI = 0.96–1.05; χ2 =
0.09; p = 0.76; DDF OR = 1.05; 95%CI = 0.99–1.12;
χ2 = 2.80; p = 0.09; EOT OR = 1.01; 95%CI = 0.95–
1.06; χ2 = 0.06; p = 0.80; TAS-20 total score OR = 1.01;
95%CI = 0.99–1.03; χ2 = 0.73; p = 0.39).
4. Discussion
The present study aimed to evaluate the role of
alexithymia in predicting the first depressive episode
(incident depression) in never-depressed patients after their
first acute coronary syndrome.
All the previous studies evaluated alexithymia in patients
with recurrent episodes of coronary artery disease and in this
population alexithymia has been associated with previous
myocardial infarction or angina episodes [6–8,38]. Moreover,
in these patients alexithymia has also been related with
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comorbid depression [9,11,38]. In contrast, in the present study
alexithymia could not be associated at baseline with chronic
coronary artery disease or with comorbid depression because
only patients at their first acute coronary syndrome andwithout
previous or current depressive episodes were enrolled.
In this study, patients who developed a depressive
episode showed few days after their first acute coronary
syndrome higher levels of DIF than subjects who maintained
a non-depressed condition during the following year.
Further, in those patients who developed depressive episode
the rate of alexithymia at baseline was higher (24.2%) than in
those who did not (9.7%), resulting in a three-fold increase in
the risk of developing depression. Therefore, the TAS-20
scores assessed few days after an acute coronary syndrome
and before the development of a depressive episode seem to
increases the risk of depression, as suggested for patients
without coronary artery disease [14,51–55].
Nevertheless, in the Cox regression analysis nor the
TAS-20 total score at baseline nor the single factors
predicted the development of a depressive episode.
There are at least two possible explanations for this finding.
Firstly, alexithymia may be a temporary response to a
stressful condition, such as an acute coronary syndrome; in
this view “secondary alexithymia” can represent a defense or
a strategy to cope with distress (emotional pain, aversive
memories and physiological arousal) associated with a
life-threatening situation as previously hypothesized [38].
In the second hypothesis, the relationship between
alexithymia and depression may represent an artifact of the
method and measures used [63], since, particularly the
TAS-20 dimensions DIF and DDF are associated with
different measures of negative affects [15,16,56–63].
Therefore, individuals with negative emotional states (i.e.
anxiety and depression) might score higher on these TAS-20
dimensions. This hypothesis is supported by previous
studies, which found that alexithymia was significantly
related with anxiety and depression in patients with an acute
coronary syndrome [9,11,38].
Specifically, in the present study, the baseline differences
in the difficulty in identifying feelings between depressed
and never-depressed, disappeared after controlling for
anhedonic symptoms. This result confirm previous data in
literature that suggest that this factor of TAS-20 measures
mainly a secondary alexithymia related to anhedonic
symptoms of depression [64], but not others that did not
found an overlap between anhedonia and alexithymia in
healthy subjects [65]. Nonetheless, even those features of
alexithymia that should be less state-dependent (i.e. EOT)
[64,66], and not related to the anhedonic dimension in our
sample (r = .066; p = 0.30) were not predictive of the
development of depression.
The results of the present study do not support the notion
that high TAS-20 scores increase the risk for developing a
depressive disorder after an acute coronary syndrome, as
already suggested in patients without coronary artery disease
[67,68]. Instead, our results uphold the explanation that the
assessment of alexithymia with TAS-20 few days after an
acute coronary syndrome probably captures negative
emotions following a life-threatening event. The data of
this study also confirm the observation of significant
relationships between alexithymia, assessed with the
TAS-20, and negative affects or psychological distress
Fig. 1. Kaplan–Meier curve of the cumulative incidence, calculated as one minus survival, of depressive episodes (n = 66) over the follow-up period (2 years).
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found in the general population [56,69]. Our data replicate
the results of one of these studies [59] which found in the
general population that the development of major depression
was not predicted by TAS-20 score.
4.1. Limitations
Possible limitations of our study are the use of self-
administered scale of alexithymia [70], where a structured
interview is more stable and consistently related to negative
affects. Therefore, the findings of the present study, based
only on a self-reported measure of alexithymia, need to be
confirmed by researches using on observer ratings (e.g.,
Toronto Structured Interview for alexithymia) [71] or
objective performance-based tasks such as the Levels of
Emotional Awareness Scale [72].
Moreover, we cannot say when the feeling of anxiety and
worries as much as the feelings of lack of pleasure or interest
observed fewdays after the cardiac event appeared, specifically if
their appearance preceded or followed the occurrence of the
acute coronary syndrome. Regardless they represent a psycho-
logical disposition or a psychological reaction to an acute
coronary syndrome, they do not satisfied at the time of inclusion
in the study the diagnostic criteria for amajor depressive episode.
5. Conclusion
The present study supports the hypothesis that the
TAS-20, the most widely used self-administered scale
assessing alexithymia, is overly sensitive to a general
distress syndrome, and therefore it is more likely to measure
negative affects (distress, nervousness, fear, anger, guilt,
sadness, scornfulness) rather than alexithymia itself. In this
view, patients after the first acute coronary syndrome
reported high levels of alexithymia, assessed with TAS-20,
because they present a psychological distress rather than a
personality characterized by disordered affect regulation.
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Table 1
Socio-demographic characteristics of patients distinguished according to their depressive condition.
Depression No Depression
n. 66 n. 185
Gender (male) 46 (69.7%) 157 (84.9%) F+ = 7.2 p = 0.01
Age (years) 62.6 ± 10.7 60.8 ± 10.9 F = 0.3 p = 0.26
Education F+ = 1.3 p = 0.73
Primary school 13 (19.7%) 31 (16.8%)
Lower secondary school 21 (31.8%) 73 (39.5%)
Higher secondary school 27 (40.9%) 67 (36.2%)
University 5 (7.6%) 14 (7.6%)
Family status F+ = 9.9 p = 0.02
Never married 7 (10.6%) 22 (11.9%)
Married 42 (63.6%) 142 (76.8%)
Separated/divorced 7 (10.6%) 13 (7.0%)
Widowed 10 (15.2%) 8 (4.3%)
Living status (alone) 18 (27.3%) 24 (13.0%) F+ = 7.1 p = 0.01
Occupation F+ = 9.2 p = 0.03
Unemployed 2 (3.0%) 3 (1.6%)
Retired 33 (50.0%) 96 (51.9%)
Housewife 7 (10.6%) 4 (2.2%)
Employed 24 (22.6%) 82 (44.3%)
GRACE score 130.7 ± 29.0 131.0 ± 29.1 F = 0.07 p = 0.93
HADS scores at baseline
Anxiety 9.27 ± 4.5 8.4 ± 5.5 F = 20.7 p = 0.22
Depression 8.33 ± 4.1 6.0 ± 4.1 F = 0.73 p b 0.001
TAS-20 scores at baseline
DIF 17.1 ± 6.1 14.2 ± 5.5 F = 0.55 p = 0.02
DDF 13.5 ± 4.2 12.8 ± 4.2 F = 0.01 p = 0.19
EOT 21.4 ± 4.2 21.0 ± 4.4 F = 0.69 p = 0.55
Total 52.1 ± 12.1 48.1 ± 10.9 F = 0.59 p = 0.02
Total N 60 16 (24.2%) 18 (9.7%) F+ = 8.7 p = 0.006
HADS (Hospital Anxiety and Depression Scale): anxiety and depression subscales.
TAS-20 (Toronto Alexithymia Scale, 20 items): DIF, difficulty identifying feelings; DDF, difficulty describing feelings, EOT, externally-oriented thinking.
F = one-way ANOVA; F+ = Fisher’s exact test.
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